Global Pharmaceutical Contract Development And Manufacturing Organization Market Size & Outlook
Global pharmaceutical contract development and manufacturing organization market, 2021-2033 (US$M)
Related Markets
Global pharmaceutical contract development and manufacturing organization market highlights
- The global pharmaceutical contract development and manufacturing organization market generated a revenue of USD 155,508.3 million in 2024 and is expected to reach USD 293,554.9 million by 2033.
- The market is expected to grow at a CAGR (2025 - 2033) of 7.4% by 2033.
- In terms of segment, small molecule accounted for a revenue of USD 108,399.3 million in 2024.
- Large Molecule is the most lucrative type segment registering the fastest growth during the forecast period.
- In terms of region, Asia Pacific was the largest revenue generating market in 2024.
- Country-wise, China is expected to register the highest CAGR from 2025 to 2033.
Global data book summary
| Market revenue in 2024 | USD 155,508.3 million |
| Market revenue in 2033 | USD 293,554.9 million |
| Growth rate | 7.4% (CAGR from 2025 to 2033) |
| Largest segment | Small molecule |
| Fastest growing segment | Large Molecule |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Small Molecule, Large Molecule |
Other key industry trends
- In terms of revenue, the North America accounted for 28.0% of the global pharmaceutical contract development and manufacturing organization market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
- By country, China is the fastest growing regional market and is projected to reach USD 39,514.1 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Pharmaceutical Contract Development And Manufacturing Organization Market Scope
Pharmaceutical Contract Development And Manufacturing Organization Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Recipharm AB | View profile | - | - | - |
| Jubilant Pharmova | View profile | 10001+ | Noida, Uttar Pradesh, India, Asia | https://www.jubilantpharmova.com |
| Almac Group | View profile | 1001-5000 | Craigavon, Craigavon, United Kingdom, Europe | https://www.almacgroup.com |
| Cambrex | View profile | 1001-5000 | East Rutherford, New Jersey, United States, North America | http://www.cambrex.com |
| CordenPharma | View profile | 5001-10000 | Plankstadt, Baden-Wurttemberg, Germany, Europe | http://cordenpharma.com |
| Vetter Pharma-Fertigung | View profile | 5001-10000 | Ravensburg, Baden-Wurttemberg, Germany, Europe | https://www.vetter-pharma.com/en |
| Piramal Pharma Solutions | View profile | 1001-5000 | Riverview, Michigan, United States, North America | http://www.piramalpharmasolutions.com/ |
| Samsung BioLogics | View profile | 1001-5000 | Incheon, Inch'on-jikhalsi, South Korea, Asia | https://www.samsungbiologics.com/ |
| Siegfried Holding AG | View profile | 4180 | Untere Bruehlstrasse 4, Zofingen, Switzerland, CH-4800 | https://www.siegfried.ch |
| Catalent Inc | View profile | 17219 | 14 Schoolhouse Road, Somerset, NJ, United States, 08873 | https://www.catalent.com |
| Wuxi AppTec Co Ltd | View profile | 41116 | 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, China, People's Republic of, 200131 | https://www.wuxiapptec.com |
| Eurofins Scientific SE | View profile | 61798 | 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 | https://www.eurofins.com |
| ThermoGenesis Holdings Inc | View profile | 25 | 2711 Citrus Road, Rancho Cordova, CA, United States, 95742 | https://www.thermogenesis.com |
| Lonza Group Ltd | View profile | 18000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | https://www.lonza.com |
Global pharmaceutical contract development and manufacturing organization market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical contract development and manufacturing organization market will help companies and investors design strategic landscapes.
Small molecule was the largest segment with a revenue share of 69.71% in 2024. Horizon Databook has segmented the Global pharmaceutical contract development and manufacturing organization market based on small molecule, large molecule covering the revenue growth of each sub-segment from 2021 to 2033.
- Global Pharmaceutical Contract Development And Manufacturing Organization Type Outlook (Revenue, USD Million, 2021-2033)
- Small Molecule
- Branded
- Generic
- Large Molecule
- Biologics
- Biosimilar
- Small Molecule
- Global Pharmaceutical Contract Development And Manufacturing Organization Pharmaceutical Outlook (Revenue, USD Million, 2021-2033)
- API
- Traditional API
- HP-API
- Biologics
- Others
- Drug Product
- Oral topical dose
- Semi-solid dose
- Liquid dose
- Others
- API
- Global Pharmaceutical Contract Development And Manufacturing Organization Services Outlook (Revenue, USD Million, 2021-2033)
- Contract Development
- Preformulation & Formulation Development Services
- Process Development & Optimization
- Analytical Testing & Method Validation
- Scale-up & Tech Transfer
- Contract Manufacturing
- API Manufacturing
- Finished drug products Manufacturing
- Packaging and labelling
- Regulatory Affairs
- Others
- Contract Development
- Global Pharmaceutical Contract Development And Manufacturing Organization Workflow Outlook (Revenue, USD Million, 2021-2033)
- Clinical
- Commercial
- Global Pharmaceutical Contract Development And Manufacturing Organization Therapeutic Area Outlook (Revenue, USD Million, 2021-2033)
- Oncology
- Infectious Diseases
- Neurological Disorders
- Cardiovascular Disease
- Metabolic Disorders
- Autoimmune Diseases
- Respiratory Diseases
- Ophthalmology
- Gastrointestinal Disorders
- Orthopedic Diseases
- Dental Diseases
- Others
- Global Pharmaceutical Contract Development And Manufacturing Organization End Use Outlook (Revenue, USD Million, 2021-2033)
- Small Pharmaceutical Companies
- Medium Pharmaceutical Companies
- Large Pharmaceutical Companies
Reasons to subscribe to Global pharmaceutical contract development and manufacturing organization market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global pharmaceutical contract development and manufacturing organization market databook
-
Our clientele includes a mix of pharmaceutical contract development and manufacturing organization market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global pharmaceutical contract development and manufacturing organization market , including forecasts for subscribers. This global databook contains high-level insights into Global pharmaceutical contract development and manufacturing organization market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Global pharmaceutical contract development and manufacturing organization market size, by regions, 2021-2033 (US$M)
Top 10 countries: Pharmaceutical contract development and manufacturing organization market size, 2024 (US$M)
Global pharmaceutical contract development and manufacturing organization market share, by type, 2024 & 2033 (%, US$M)
Pharmaceutical contract development and manufacturing organization market: Opportunity assessment by country
Global pharmaceutical contract development and manufacturing organization market, by region, 2024 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
